Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selegiline for Excessive Daytime Sleepiness in Parkinson's Disease
NCT04870372Phase 4Completed
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Mar 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of selegiline in Parkinson's disease (PD), sponsored by The Second Affiliated Hospital of Soochow University. Started Mar 2020; status: completed.
02
Drugs
selegiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04870372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04870372.